Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03657602 · ClinicalTrials.gov registry record · Early Phase 1
Immediate Postpartum Insertion of Contraceptive Intrauterine Devices
A Early Phase 1 study, sponsored by University of Oklahoma.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 28
- Enrollment target
NCT03657602 is a Early Phase 1 study that has completed, run by University of Oklahoma. The registered enrollment target is 28 participants.
The verdict
NCT03657602, a Early Phase 1 study, has completed, sponsored by University of Oklahoma.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 28 participants
- Enrollment target
Study Summary
In this randomized trial, investigators intend to determine the expulsion and discontinuation rate of immediate postpartum intrauterine devices in the patient population of the University of Oklahoma Women's Healthcare Specialists Clinic (OUWHSC).
Interventions
- DRUG Kyleena Intrauterine System
- DRUG Mirena Intrauterine System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2019-12-15 |
| Est. Completion | 2023-01-15 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03657602
The ClinicalTrials.gov registry entry for NCT03657602 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Oklahoma, which has 358 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Kyleena Intrauterine System is the first listed.
NCT03657602 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03657602 about?
NCT03657602 is a clinical study titled "Immediate Postpartum Insertion of Contraceptive Intrauterine Devices". In this randomized trial, investigators intend to determine the expulsion and discontinuation rate of immediate postpartum intrauterine devices in the patient population of the University of Oklahoma Women's Healthcare Specialists Clinic (OUWHSC).
What is the current status of trial NCT03657602?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 28 participants. The study started on 2019-12-15. Estimated completion is 2023-01-15.
What interventions are being tested in trial NCT03657602?
The interventions under investigation include: Kyleena Intrauterine System (DRUG), Mirena Intrauterine System (DRUG).
Who is sponsoring clinical trial NCT03657602?
This trial is sponsored by University of Oklahoma, which has 358 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.